Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights

Abstract

Miguel Román-Rodríguez,1,2 Ilona McMullan,3 Michelle Warner,3 Christopher H Compton,3 Ruth Tal-Singer,4 Jean M Orlow,5 MeiLan K Han6 1Centro de Salud Dra. Teresa Pique, Mallorca, Spain; 2Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Mallorca, Spain; 3GSK, London, UK; 4Global Allergy and Airways Patient Platform, Vienna, Austria; 5COPD Patient and COPD Foundation Community Member, Miami, FL, USA; 6Division of Pulmonary and Critical Care Medicine, University of Michigan School of Medicine, MI, USACorrespondence: Miguel Román-Rodríguez, Centro de Salud Dra. Teresa Pique, Mallorca, Spain, Email [email protected]: Asthma and chronic obstructive pulmonary disease (COPD) are associated with substantial morbidity and mortality. This analysis assessed patient, caregiver, and healthcare provider (HCP) opinions regarding asthma and COPD diagnosis and treatment, including inhaler device preferences.Patients and Methods: Insights were from: (1) face-to-face/telephone patient/HCP communications with GSK Global Medical Teams; (2) social media listening; (3) a self-completed online patient/caregiver survey. Data were anonymized and informed consent was provided. Qualitative outputs were extracted, analyzed inductively, and coded per key themes, such as treatment preferences (including perceptions of single inhaler triple therapy [SITT] versus multiple inhaler triple therapy [MITT]) and long-term treatment goals. Data could be assigned to ≥ 1 theme.Results: Overall, 2966 patient and HCP insights (patients, 1150; HCPs, 1816), 988 social media posts, and 44 survey responses (patients, 33; caregivers, 11) were included. Within this analysis, some patients delayed seeking medical advice due to lack of disease understanding and used alternative information sources to better understand treatment options (eg, social media). Patients preferred SITT over MITT in terms of convenience, ease of use, and perceived efficacy; some believed that MITT provided greater coverage due to frequent dosing. HCPs recognized the tendency of patient preferences to drive treatment decisions, and highlighted a reluctance to change therapy among some patients, particularly those well controlled in current therapy. Patients preferred therapies with a shorter onset of action. Patients tended to measure treatment success by symptom improvement and quality of life, whereas HCPs measured treatment success through clinical tests. HCPs reported a lack of patient awareness of the mortality risk associated with COPD.Conclusion: There is discordance between patient and HCP perceptions of treatment success and goals in asthma and COPD. Improved patient education and HCP-patient communication are needed to facilitate meaningful shared decision-making, optimize care plans, and provide early treatment options.Keywords: single inhaler triple therapy, multiple inhaler triple therapy, treatment goals, medical advice, patient education, quality of life

Keywords

• single inhaler triple therapy
• multiple inhaler triple therapy
• treatment goals
• medical advice
• patient education
• quality of life